MARY HITCHCOCK MEMORIAL HOSP

Type: Teaching hospital
Where: Lebanon, NH
Medicare CCN: 300003
Received: $5,159,791 in 969 records, 2019 ($323,510 general, $4,836,281 research)
Source: CMS Open Payments search ↗

By year

Program year	Kind	Records	Amount
2019	General payment	118	$323,510
2019	Research payment	851	$4,836,281

By company

Company	Records	Amount	Years
TESARO, Inc.	25	$915,267	2019
ABBVIE INC.	149	$495,871	2019
Eli Lilly and Company	20	$369,316	2019
PFIZER INC.	118	$251,544	2019
ZOLL Medical Corporation	4	$250,431	2019
VERTEX PHARMACEUTICALS INCORPORATED	11	$246,361	2019
Genentech, Inc.	32	$209,560	2019
Grifols Therapeutics LLC	19	$182,329	2019
Vascular Graft Solutions Inc	1	$160,200	2019
Celgene Corporation	8	$141,870	2019
Gilead Sciences, Inc.	29	$131,634	2019
GW Research Limited	60	$121,317	2019
Edwards Lifesciences Corporation	16	$120,778	2019
SANOFI PASTEUR INC.	4	$119,750	2019
Merck Sharp & Dohme LLC	16	$108,400	2019
Boston Scientific Corporation	39	$104,828	2019
Eisai Inc.	44	$98,581	2019
Abbott Laboratories	15	$97,818	2019
AstraZeneca UK Limited	4	$79,724	2019
Boehringer Ingelheim Pharmaceuticals, Inc.	5	$76,860	2019
W. L. Gore & Associates, Inc.	33	$65,446	2019
Tryton Medical, Inc.	1	$54,342	2019
Bayer Healthcare Pharmaceuticals Inc.	20	$45,895	2019
Dompe US, Inc.	3	$43,284	2019
Relievant Medsystems, Inc.	2	$42,011	2019
Medtronic Vascular, Inc.	7	$39,513	2019
Medical Device Business Services, Inc.	20	$39,221	2019
SUN PHARMACEUTICAL INDUSTRIES INC.	22	$36,265	2019
Amgen Inc.	14	$34,816	2019
Incyte Corporation	35	$33,873	2019
NEUROPACE, INC.	5	$30,796	2019
Kyowa Kirin Pharmaceutical Development, Inc	5	$29,288	2019
Janssen Research & Development, LLC	11	$27,103	2019
Erbe Elektromedizin GmbH	1	$26,487	2019
AstraZeneca Pharmaceuticals LP	4	$25,110	2019
United Therapeutics Corporation	11	$20,703	2019
E.R. Squibb & Sons, L.L.C.	9	$20,092	2019
TAIHO ONCOLOGY, INC.	5	$19,263	2019
Allergan, Inc.	2	$18,803	2019
Regeneron Pharmaceuticals, Inc.	6	$15,643	2019
Siemens Medical Solutions USA, Inc.	2	$15,089	2019
Astellas Pharma Global Development	10	$13,482	2019
AngioDynamics, Inc.	1	$13,000	2019
Amneal Pharmaceuticals LLC	3	$11,200	2019
Ferring International Pharmascience Center US	4	$9,273	2019
ClearPoint Neuro, Inc.	1	$9,260	2019
Ipsen Biopharmaceuticals, Inc	5	$8,750	2019
Takeda Pharmaceuticals U.S.A., Inc.	2	$8,200	2019
Biogen, Inc.	1	$7,975	2019
Intuitive Surgical, Inc.	1	$7,228	2019

By nature of payment

Nature	Records	Amount
Research payment	851	$4,836,281
Grant	12	$141,204
Space rental or facility fees (teaching hospital only)	71	$90,400
Education	19	$53,729
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing	5	$27,500
Compensation for services other than consulting, including serving as faculty or as a speaker at a v	6	$4,436
Consulting Fee	2	$4,410
Gift	2	$1,740
Charitable Contribution	1	$89

Records

Date	Company	Amount	Nature	Form	Product	Study	Year
2019-12-31	Allergan, Inc.	$17,303	Research payment	Cash or cash equivalent		AURORA A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of	2019
2019-12-31	AngioDynamics, Inc.	$13,000	Education	In-kind items and services	Solero Device, Oncology Surgery		2019
2019-12-31	Intuitive Surgical, Inc.	$7,228	Education	In-kind items and services	Da Vinci Surgical System Device, SURGERY		2019
2019-12-31	AstraZeneca UK Limited	$1,746	Research payment	In-kind items and services		This is an open label non randomised study designed to provide continued access to AZD1775 for eligible patients with ad	2019
2019-12-31	Masimo Corporation	$1,037	Education	In-kind items and services	SET and rainbow SET Device, Devices		2019
2019-12-31	Masimo Corporation	$518	Education	In-kind items and services	rainbow Acoustic Monitoring Device, Devices		2019
2019-12-31	Masimo Corporation	$506	Education	In-kind items and services	SET and rainbow SET Device, Devices		2019
2019-12-31	Masimo Corporation	$443	Education	In-kind items and services	rainbow Acoustic Monitoring Device, Devices		2019
2019-12-31	Masimo Corporation	$162	Education	In-kind items and services	SET and rainbow SET Device, Devices		2019
2019-12-31	Siemens Medical Solutions USA, Inc.	$89	Charitable Contribution	In-kind items and services			2019
2019-12-31	Masimo Corporation	$68	Education	In-kind items and services	SedLine Device, Devices		2019
2019-12-30	ABBVIE INC.	$13,866	Research payment	Cash or cash equivalent	Skyrizi Biological, Immunology	M15-998	2019
2019-12-30	Eli Lilly and Company	$13,260	Research payment	Cash or cash equivalent		RANDOMIZED CONTROLLED TRIAL OF LASMIDITAN OVER FOUR MIGRAINE ATTACKS	2019
2019-12-30	ABBVIE INC.	$6,734	Research payment	Cash or cash equivalent		M16-063	2019
2019-12-27	Vascular Graft Solutions Inc	$160,200	Research payment	Cash or cash equivalent	VEST Device	VEST Venous Graft External Support Pivotal Study	2019
2019-12-27	PFIZER INC.	$2,800	Research payment	Cash or cash equivalent	IBRANCE Drug, ONCOLOGY	PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI	2019
2019-12-26	United Therapeutics Corporation	$6,467	Research payment	Cash or cash equivalent	ORENITRAM Drug, PAH	A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ORAL TREPROSTIN	2019
2019-12-26	United Therapeutics Corporation	$6,467	Research payment	Cash or cash equivalent	ORENITRAM Drug, PAH	AN OPEN-LABEL EXTENSION STUDY OF ORAL TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION PH ASSOCIATED WITH HEART FAIL	2019
2019-12-20	ABBVIE INC.	$7,618	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-572	2019
2019-12-20	Genentech, Inc.	$3,313	Research payment	Cash or cash equivalent	Avastin Biological, BioOncology	A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM	2019
2019-12-20	W. L. Gore & Associates, Inc.	$3,000	Research payment	Cash or cash equivalent	Carotid Stent Device, Devices	GORE Carotid Stent Clinical Study for the treatment of carotid artery stenosis in patients at increased risk for adverse	2019
2019-12-19	Regeneron Pharmaceuticals, Inc.	$1,500	Research payment	Cash or cash equivalent		A Phase 1 Study to Assess Safety and Tolerability of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody, a	2019
2019-12-19	Bayer Healthcare Pharmaceuticals Inc.	$1,250	Research payment	Cash or cash equivalent	Mirena Drug, Women's Health	BAY86-5028 Mirena extension contraception	2019
2019-12-19	ABBVIE INC.	$242	Research payment	Cash or cash equivalent	Skyrizi Biological, Immunology	M15-998	2019
2019-12-18	SUN PHARMACEUTICAL INDUSTRIES INC.	$2,036	Research payment	Cash or cash equivalent	ILUMYA Biological, Dermatology	A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankyl	2019
2019-12-18	SUN PHARMACEUTICAL INDUSTRIES INC.	$1,500	Research payment	Cash or cash equivalent	ILUMYA Biological, Dermatology	A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankyl	2019
2019-12-16	Gilead Sciences, Inc.	$12,702	Research payment	Cash or cash equivalent		A Long-term Extension Study of Filgotinib Safety and Efficacy in Subjects with Rheumatoid Arthritis	2019
2019-12-16	Boston Scientific Corporation	$5,416	Research payment	Cash or cash equivalent	CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT	ASAP TOO	2019
2019-12-16	ABBVIE INC.	$1,791	Research payment	Cash or cash equivalent	Skyrizi Biological, Immunology	M15-998	2019
2019-12-16	Boston Scientific Corporation	$650	Research payment	Cash or cash equivalent	CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT	ASAP TOO	2019
2019-12-16	Boston Scientific Corporation	$195	Research payment	Cash or cash equivalent	CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT	ASAP TOO	2019
2019-12-13	Edwards Lifesciences Corporation	$8,501	Research payment	Cash or cash equivalent		Early-TAVR Trial 2016-07	2019
2019-12-13	Spiration, Inc.	$1,500	Research payment	Cash or cash equivalent	Spiration Valve System Device, EndoTherapy Products	Valves Against Standard Therapy	2019
2019-12-13	Medical Device Business Services, Inc.	$1,349	Research payment	Cash or cash equivalent	ATTUNE Device, Ortho-Knee	Multi-Center Clinical Evaluation of the ATTUNE Revision System in Complex Primary Total Knee Arthroplasty	2019
2019-12-13	W. L. Gore & Associates, Inc.	$962	Research payment	Cash or cash equivalent	Product in Development Device, Devices	GORE EXCLUDER Conformable Endoprosthesis	2019
2019-12-12	Ipsen Biopharmaceuticals, Inc	$2,500	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	SOMATULINE DEPOT Drug, Oncology/Endocrinology		2019
2019-12-12	ABBVIE INC.	$1,500	Research payment	Cash or cash equivalent		M16-063	2019
2019-12-12	ABBVIE INC.	$1,500	Research payment	Cash or cash equivalent		M16-063	2019
2019-12-12	Medical Device Business Services, Inc.	$221	Research payment	Cash or cash equivalent	ATTUNE Device, Ortho-Knee	Multi-Center Clinical Evaluation of the ATTUNE Revision System in Complex Primary Total Knee Arthroplasty	2019
2019-12-11	NEUROPACE, INC.	$1,500	Research payment	Cash or cash equivalent	RNS System Device, Epilepsy	Post Approval Study	2019
2019-12-11	Merck Sharp & Dohme LLC	$656	Research payment	In-kind items and services	KEYTRUDA Biological, ONCOLOGY	A Phase 2 Umbrella Study with Rolling Arms of Investigational Agents with either Pembrolizumab in Combination with Chemo	2019
2019-12-11	EKOS Corporation	$221	Research payment	Cash or cash equivalent	EKOSONIC Device, PERIPHERAL VASCULAR	KNOCOUT PE	2019
2019-12-10	ABBVIE INC.	$3,588	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-555	2019
2019-12-10	ABBVIE INC.	$714	Research payment	Cash or cash equivalent	Skyrizi Biological, Immunology	M15-998	2019
2019-12-10	ABBVIE INC.	$41	Research payment	Cash or cash equivalent	Skyrizi Biological, Immunology	M15-998	2019
2019-12-09	ZOLL Medical Corporation	$118,856	Research payment	Cash or cash equivalent	Device, DEFIBRILLATOR		2019
2019-12-09	Janssen Research & Development, LLC	$1,045	Research payment	Cash or cash equivalent		A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study	2019
2019-12-06	Abbott Laboratories	$5,500	Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing	Cash or cash equivalent	Xience Xpedition coronary stent system Device, Vascular		2019
2019-12-06	Medical Device Business Services, Inc.	$3,672	Research payment	Cash or cash equivalent	ATTUNE Device, Ortho-Knee	Multi-Center Clinical Evaluation of the ATTUNE Revision System in Complex Primary Total Knee Arthroplasty	2019
2019-12-06	PFIZER INC.	$3,400	Research payment	Cash or cash equivalent	IBRANCE Drug, ONCOLOGY	PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI	2019
2019-12-06	ABBVIE INC.	$1,445	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-555	2019
2019-12-06	W. L. Gore & Associates, Inc.	$1,397	Research payment	Cash or cash equivalent	Product in Development Device, Devices	Evaluation of the GORE TAG TSSB-LSA Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms	2019
2019-12-06	W. L. Gore & Associates, Inc.	$1,397	Research payment	Cash or cash equivalent	Product in Development Device, Devices	Evaluation of the GORE TAG TSSB-LSA Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms	2019
2019-12-06	W. L. Gore & Associates, Inc.	$195	Research payment	Cash or cash equivalent	Product in Development Device, Devices	Evaluation of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararena	2019
2019-12-06	ABBVIE INC.	$180	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M14-533	2019
2019-12-06	Edwards Lifesciences Corporation	$110	Research payment	Cash or cash equivalent	Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves	Early-TAVR Trial 2016-07	2019
2019-12-06	Edwards Lifesciences Corporation	$110	Research payment	Cash or cash equivalent	Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves	Early-TAVR Trial 2016-07	2019
2019-12-05	Abbott Laboratories	$10,310	Research payment	Cash or cash equivalent	ABSORB Device, Vascular	A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects	2019
2019-12-05	Incyte Corporation	$4,292	Research payment	Cash or cash equivalent		PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO	2019
2019-12-05	ABBVIE INC.	$4,235	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M14-533	2019
2019-12-05	PFIZER INC.	$2,210	Consulting Fee	Cash or cash equivalent			2019
2019-12-05	Incyte Corporation	$225	Research payment	Cash or cash equivalent		PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO	2019
2019-12-04	Edwards Lifesciences Corporation	$2,804	Research payment	Cash or cash equivalent		PARTNER II 2010-12	2019
2019-12-04	Edwards Lifesciences Corporation	$1,500	Research payment	Cash or cash equivalent	Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves	Early-TAVR Trial 2016-07	2019
2019-12-03	Genentech, Inc.	$1,206	Research payment	Cash or cash equivalent	Alecensa Biological, BioOncology	B FAST BLOOD FIRST ASSAY SCREENING TRIAL UMBRELLA STUDY	2019
2019-12-02	Gilead Sciences, Inc.	$650	Research payment	Cash or cash equivalent		A Long-term Extension Study of Filgotinib Safety and Efficacy in Subjects with Rheumatoid Arthritis	2019
2019-11-28	PFIZER INC.	$2,957	Research payment	Cash or cash equivalent	XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT	A LONGTERM OPENLABEL EXTENSION STUDY OF TOFACITINIB CP690550 FOR THE TREATMENT OF PSORIATIC ARTHRITIS	2019
2019-11-27	ABBVIE INC.	$15,741	Research payment	Cash or cash equivalent	Skyrizi Biological, Immunology	M15-998	2019
2019-11-27	Edwards Lifesciences Corporation	$917	Research payment	Cash or cash equivalent		Partner3 2015-08	2019
2019-11-26	ABBVIE INC.	$6,869	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-572	2019
2019-11-26	EKOS Corporation	$1,500	Research payment	Cash or cash equivalent	EKOSONIC Device, PERIPHERAL VASCULAR	KNOCOUT PE	2019
2019-11-26	Amneal Pharmaceuticals LLC	$1,500	Research payment	Cash or cash equivalent	ZOMIG Drug, FAMILY MEDICINE	A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZOLM	2019
2019-11-26	Astellas Pharma Global Development	$1,000	Research payment	Cash or cash equivalent	XOSPATA Drug, ONCOLOGY	A Phase 3 Open-label, Multicenter, Randomized Study of ASP2215 versus Salvage Chemotherapy in Patients with Relapsed or	2019
2019-11-26	EKOS Corporation	$221	Research payment	Cash or cash equivalent	EKOSONIC Device, PERIPHERAL VASCULAR	KNOCOUT PE	2019
2019-11-26	Astellas Pharma Global Development	$153	Research payment	Cash or cash equivalent	XOSPATA Drug, ONCOLOGY	A Phase 3 Open-label, Multicenter, Randomized Study of ASP2215 versus Salvage Chemotherapy in Patients with Relapsed or	2019
2019-11-25	ZOLL Medical Corporation	$9,339	Research payment	Cash or cash equivalent	Device, DEFIBRILLATOR		2019
2019-11-25	ABBVIE INC.	$2,981	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-555	2019
2019-11-25	Janssen Research & Development, LLC	$2,600	Research payment	Cash or cash equivalent		A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study	2019
2019-11-25	Janssen Biotech, Inc.	$500	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	DARZALEX Biological, Oncology		2019
2019-11-22	ABBVIE INC.	$4,530	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M13-542	2019
2019-11-22	Genentech, Inc.	$720	Research payment	Cash or cash equivalent	Zelboraf Biological, BioOncology	PHASE III BRAF MEK COMBINATION	2019
2019-11-21	Eli Lilly and Company	$1,525	Research payment	In-kind items and services		A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 CROSSOVER STUDY TO EVALUATE THE EFFICACY AND SAFETY	2019
2019-11-21	ABBVIE INC.	$1,500	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M14-533	2019
2019-11-21	Boehringer Ingelheim Limited	$56	Research payment	In-kind items and services	OFEV Drug, ONCOLOGY	Nintedanib in PF-ILD (extension)	2019
2019-11-21	Boehringer Ingelheim Limited	$56	Research payment	In-kind items and services	OFEV Drug, RESPIRATORY	Nintedanib in PF-ILD (extension)	2019
2019-11-20	Gilead Sciences, Inc.	$4,544	Research payment	Cash or cash equivalent		A Long-term Extension Study of Filgotinib Safety and Efficacy in Subjects with Rheumatoid Arthritis	2019
2019-11-20	Merck Sharp & Dohme LLC	$3,300	Research payment	Cash or cash equivalent	KEYTRUDA Biological, ONCOLOGY	A Randomized open-Label Phase III Trial of Pembrolizumab versus Platinum based Chemotherapy in 1L Subjects with PD-L1 St	2019
2019-11-20	SUN PHARMACEUTICAL INDUSTRIES INC.	$2,491	Research payment	Cash or cash equivalent	ILUMYA Biological, Dermatology	A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankyl	2019
2019-11-20	SUN PHARMACEUTICAL INDUSTRIES INC.	$1,528	Research payment	Cash or cash equivalent	ILUMYA Biological, Dermatology	A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankyl	2019
2019-11-20	Medical Device Business Services, Inc.	$696	Research payment	Cash or cash equivalent	ACTIS Device, Ortho-Hip	Actis Total Hip System 2 Year Follow-up	2019
2019-11-19	TESARO, Inc.	$66,906	Research payment	In-kind items and services	ZEJULA Drug, ONCOLOGY	PHASE 2, A STUDY OF NIRAPARIB COMBINED WITH BEVACIZUMAB MAINTENANCE TREATMENT IN PATIENTS WITH ADVANCED OVARIAN CANCER F	2019
2019-11-18	Alexion Pharmaceuticals, Inc.	$1,200	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	Strensiq Drug, Endocrinology		2019
2019-11-18	ABBVIE INC.	$422	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M14-234	2019
2019-11-15	Edwards Lifesciences Corporation	$25,000	Grant	Cash or cash equivalent			2019
2019-11-14	NEUROPACE, INC.	$9,450	Research payment	Cash or cash equivalent	RNS System Device, Epilepsy	Post Approval Study	2019
2019-11-13	E.R. Squibb & Sons, L.L.C.	$1,500	Research payment	Cash or cash equivalent	ORENCIA Biological, Immunology	Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy	2019
2019-11-13	PFIZER INC.	$1,000	Research payment	Cash or cash equivalent	XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT	A MULTICENTER OPENLABEL STUDY OF CP690550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS	2019
2019-11-13	EKOS Corporation	$546	Research payment	Cash or cash equivalent	EKOSONIC Device, PERIPHERAL VASCULAR	KNOCOUT PE	2019
2019-11-13	ABBVIE INC.	$405	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-572	2019
2019-11-13	PFIZER INC.	$130	Research payment	Cash or cash equivalent	XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT	A MULTICENTER OPENLABEL STUDY OF CP690550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS	2019
2019-11-12	Genentech, Inc.	$5,109	Research payment	Cash or cash equivalent	Avastin Biological, BioOncology	A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM	2019
2019-11-12	Masimo Corporation	$739	Education	In-kind items and services	SET and rainbow SET Device, Devices		2019
2019-11-12	ABBVIE INC.	$445	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M13-542	2019
2019-11-12	Masimo Corporation	$198	Education	In-kind items and services	SET and rainbow SET Device, Devices		2019
2019-11-08	W. L. Gore & Associates, Inc.	$1,000	Research payment	Cash or cash equivalent	Product in Development Device, Devices	Evaluation of the GORE EXCLUDER Iliac Branch Endoprosthesis for the Treatment of Common Iliac Artery Aneurysms or Aorto-	2019
2019-11-08	ABBVIE INC.	$325	Research payment	Cash or cash equivalent	Skyrizi Biological, Immunology	M15-998	2019
2019-11-07	ABBVIE INC.	$1,500	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-555	2019
2019-11-07	Incyte Corporation	$799	Research payment	Cash or cash equivalent		A Randomized, Double Blind, Placebo Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroid	2019
2019-11-07	ABBVIE INC.	$240	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-572	2019
2019-11-07	ABBVIE INC.	$80	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-572	2019
2019-11-06	PFIZER INC.	$989	Research payment	Cash or cash equivalent	XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT	A MULTICENTER OPENLABEL STUDY OF CP690550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS	2019
2019-11-05	Takeda Pharmaceuticals U.S.A., Inc.	$7,200	Research payment	Cash or cash equivalent	ENTYVIO Biological, Lower GI	Entyvio-Vedolizumab- Long Term Study	2019
2019-11-05	TESARO, Inc.	$1,500	Research payment	Cash or cash equivalent	ZEJULA Drug, ONCOLOGY	A STUDY OF NIRAPARIB IN PATIENTS WITH OVARIAN CANCER WHO HAVE RECEIVED AT LEAST THREE PREVIOUS CHEMOTHERAPY REGIMENS	2019
2019-11-04	Boston Scientific Corporation	$14,565	Research payment	Cash or cash equivalent	CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT	ASAP TOO	2019
2019-11-04	Boston Scientific Corporation	$3,142	Research payment	Cash or cash equivalent	CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT	ASAP TOO	2019
2019-11-04	Medical Device Business Services, Inc.	$750	Research payment	Cash or cash equivalent	ATTUNE Device, Ortho-Knee	Multi-Center Clinical Evaluation of the ATTUNE Revision System in Complex Primary Total Knee Arthroplasty	2019
2019-11-04	Boston Scientific Corporation	$750	Research payment	Cash or cash equivalent	CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT	ASAP TOO	2019
2019-11-04	Genentech, Inc.	$148	Research payment	Cash or cash equivalent	Non-Covered Product Drug, None	B FAST BLOOD FIRST ASSAY SCREENING TRIAL UMBRELLA STUDY	2019
2019-11-04	ABBVIE INC.	$97	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M13-542	2019
2019-11-01	Alcresta Therapeutics, Inc.	$750	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	RELIZORB Device, GASTROENTEROLOGY		2019
2019-10-31	Abbott Laboratories	$25,000	Education	Cash or cash equivalent			2019
2019-10-31	ABBVIE INC.	$13,677	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-572	2019
2019-10-31	PFIZER INC.	$7,200	Research payment	Cash or cash equivalent	IBRANCE Drug, ONCOLOGY	PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI	2019
2019-10-31	Bayer Healthcare Pharmaceuticals Inc.	$1,200	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	Kyleena Drug, Women's Health		2019
2019-10-30	ABBVIE INC.	$21,701	Research payment	Cash or cash equivalent	Skyrizi Biological, Immunology	M15-998	2019
2019-10-30	PFIZER INC.	$5,766	Research payment	Cash or cash equivalent	XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT	A LONGTERM OPENLABEL EXTENSION STUDY OF TOFACITINIB CP690550 FOR THE TREATMENT OF PSORIATIC ARTHRITIS	2019
2019-10-30	ABBVIE INC.	$5,265	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-555	2019
2019-10-30	ABBVIE INC.	$325	Research payment	Cash or cash equivalent	Skyrizi Biological, Immunology	M15-998	2019
2019-10-30	SUN PHARMACEUTICAL INDUSTRIES INC.	$195	Research payment	Cash or cash equivalent	ILUMYA Biological, Dermatology	A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankyl	2019
2019-10-30	ABBVIE INC.	$130	Research payment	Cash or cash equivalent	Skyrizi Biological, Immunology	M15-998	2019
2019-10-29	Genentech, Inc.	$6,859	Research payment	Cash or cash equivalent	TECENTRIQ Biological, BioOncology	LCMC3	2019
2019-10-29	VIVUS LLC	$2,300	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	PANCREAZE Drug, GASTROENTEROLOGY		2019
2019-10-29	ABBVIE INC.	$2,230	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M16-047	2019
2019-10-29	EKOS Corporation	$442	Research payment	Cash or cash equivalent	EKOSONIC Device, PERIPHERAL VASCULAR	KNOCOUT PE	2019
2019-10-28	GW Research Limited	$11,218	Research payment	Cash or cash equivalent		GWEP1415	2019
2019-10-28	GW Research Limited	$3,256	Research payment	Cash or cash equivalent		GWEP1415	2019
2019-10-28	GW Research Limited	$1,991	Research payment	Cash or cash equivalent		GWEP1415	2019
2019-10-28	GW Research Limited	$1,667	Research payment	Cash or cash equivalent		GWEP1415	2019
2019-10-28	ABBVIE INC.	$1,510	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M13-542	2019
2019-10-28	KARL STORZ Endoscopy-America	$600	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	C-MAC S IMAGER Device, ANESTHESIOLOGY		2019
2019-10-28	GW Research Limited	$87	Research payment	Cash or cash equivalent		GWEP1415	2019
2019-10-28	Boehringer Ingelheim Limited	$81	Research payment	In-kind items and services	OFEV Drug, RESPIRATORY	Nintedanib in PF-ILD (extension)	2019
2019-10-28	Boehringer Ingelheim Limited	$81	Research payment	In-kind items and services	OFEV Drug, ONCOLOGY	Nintedanib in PF-ILD (extension)	2019
2019-10-25	Eisai Inc.	$9,288	Research payment	Cash or cash equivalent	Fycompa Drug, Neurology	A Retrospective Analysis of Cognition and Depression Correlated with AED	2019
2019-10-25	Eisai Inc.	$9,288	Research payment	Cash or cash equivalent	Fycompa Drug, Neurology	A Retrospective Analysis of Cognition and Depression Correlated with AED	2019
2019-10-25	ABBVIE INC.	$1,500	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-555	2019
2019-10-24	TESARO, Inc.	$31,192	Research payment	Cash or cash equivalent	ZEJULA Drug, ONCOLOGY	PHASE 2, A STUDY OF NIRAPARIB COMBINED WITH BEVACIZUMAB MAINTENANCE TREATMENT IN PATIENTS WITH ADVANCED OVARIAN CANCER F	2019
2019-10-24	Bayer Healthcare Pharmaceuticals Inc.	$2,787	Research payment	Cash or cash equivalent	Mirena Drug, Women's Health	BAY86-5028 Mirena extension contraception	2019
2019-10-23	Merck Sharp & Dohme LLC	$3,000	Research payment	Cash or cash equivalent	KEYTRUDA Biological, ONCOLOGY	A Randomized open-Label Phase III Trial of Pembrolizumab versus Platinum based Chemotherapy in 1L Subjects with PD-L1 St	2019
2019-10-23	Gilead Sciences, Inc.	$2,200	Research payment	Cash or cash equivalent		A Long-term Extension Study of Filgotinib Safety and Efficacy in Subjects with Rheumatoid Arthritis	2019
2019-10-21	Genentech, Inc.	$9,113	Research payment	Cash or cash equivalent	Avastin Biological, BioOncology	A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM	2019
2019-10-21	ABBVIE INC.	$3,204	Research payment	Cash or cash equivalent	Skyrizi Biological, Immunology	M15-997	2019
2019-10-19	ZOLL Medical Corporation	$121,636	Research payment	Cash or cash equivalent	Device, DEFIBRILLATOR		2019
2019-10-18	W. L. Gore & Associates, Inc.	$4,500	Research payment	Cash or cash equivalent	Product in Development Device, Devices	Evaluation of the GORE TAG TSSB-LSA Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms	2019
2019-10-18	ABBVIE INC.	$1,000	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	Mavyret Drug, Virology		2019
2019-10-16	Edwards Lifesciences Corporation	$56,519	Research payment	Cash or cash equivalent		Early-TAVR Trial 2016-07	2019
2019-10-16	TESARO, Inc.	$53,524	Research payment	In-kind items and services	ZEJULA Drug, ONCOLOGY	PHASE 2, A STUDY OF NIRAPARIB COMBINED WITH BEVACIZUMAB MAINTENANCE TREATMENT IN PATIENTS WITH ADVANCED OVARIAN CANCER F	2019
2019-10-16	Boston Scientific Corporation	$25,000	Grant	Cash or cash equivalent	GENERAL - STRUCTURAL HEART Device, STRUCTURAL HEART		2019
2019-10-16	Abbott Laboratories	$5,500	Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing	Cash or cash equivalent	Xience Xpedition coronary stent system Device, Vascular		2019
2019-10-16	PFIZER INC.	$2,600	Research payment	Cash or cash equivalent	XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT	A LONGTERM OPENLABEL EXTENSION STUDY OF TOFACITINIB CP690550 FOR THE TREATMENT OF PSORIATIC ARTHRITIS	2019
2019-10-16	PFIZER INC.	$750	Research payment	Cash or cash equivalent	XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT	A LONGTERM OPENLABEL EXTENSION STUDY OF TOFACITINIB CP690550 FOR THE TREATMENT OF PSORIATIC ARTHRITIS	2019
2019-10-15	ABBVIE INC.	$3,270	Research payment	Cash or cash equivalent	Skyrizi Biological, Immunology	M15-997	2019
2019-10-15	ABBVIE INC.	$2,200	Research payment	Cash or cash equivalent		M16-063	2019
2019-10-15	ABBVIE INC.	$325	Research payment	Cash or cash equivalent		M16-063	2019
2019-10-11	Boehringer Ingelheim Pharmaceuticals, Inc.	$31,010	Research payment	Cash or cash equivalent	OFEV Drug, RESPIRATORY	Nintedanib in PF ILD extension	2019
2019-10-11	W. L. Gore & Associates, Inc.	$1,500	Research payment	Cash or cash equivalent	Product in Development Device, Devices	TAMBE - Initial Feasibility Assessment of the GORE EXCLUDER Juxtarenal and Thoracoabcominal Branch System in the Treatme	2019
2019-10-11	Chiesi USA, Inc.	$700	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	CUROSURF Drug, NEONATOLOGY		2019
2019-10-10	SANOFI PASTEUR INC.	$71,645	Research payment	Cash or cash equivalent	YELLOW FEVER Drug	STA00011 Stamaril Yellow Fever	2019
2019-10-10	Bayer Healthcare Pharmaceuticals Inc.	$14,514	Research payment	Cash or cash equivalent	Xarelto Drug, Cardio-pulmonary	BAY59-7939 2.5mg reduction atherothrombotic events vs. ASA	2019
2019-10-10	Regeneron Pharmaceuticals, Inc.	$1,500	Research payment	Cash or cash equivalent		A Phase 1 Study to Assess Safety and Tolerability of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody, a	2019
2019-10-10	Medical Device Business Services, Inc.	$1,200	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	MemoryShape Breast Implants Device, Plastic Surgery		2019
2019-10-10	Bayer Healthcare Pharmaceuticals Inc.	$65	Research payment	Cash or cash equivalent	Xarelto Drug, Cardio-pulmonary	BAY59-7939 2.5mg reduction atherothrombotic events vs. ASA	2019
2019-10-09	ABBVIE INC.	$1,500	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M13-542	2019
2019-10-09	ABBVIE INC.	$672	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M13-542	2019
2019-10-09	EKOS Corporation	$650	Research payment	Cash or cash equivalent	EKOSONIC Device, PERIPHERAL VASCULAR	KNOCOUT PE	2019
2019-10-09	ABBVIE INC.	$560	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-572	2019
2019-10-09	ABBVIE INC.	$240	Research payment	Cash or cash equivalent	Rinvoq Biological, Immunology	M15-572	2019
2019-10-08	Incyte Corporation	$103	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$52	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$48	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$30	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$30	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$26	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$26	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$26	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$16	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$16	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$16	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$16	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$16	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$16	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$15	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$0	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-08	Incyte Corporation	$0	Research payment	Cash or cash equivalent		A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants	2019
2019-10-07	GlaxoSmithKline, LLC.	$600	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	NUCALA Biological, RESPIRATORY		2019
2019-10-07	GlaxoSmithKline, LLC.	$600	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	TRELEGY ELLIPTA Drug, RESPIRATORY		2019
2019-10-07	Medical Device Business Services, Inc.	$361	Research payment	Cash or cash equivalent	ATTUNE Device, Ortho-Knee	Multi-Center Clinical Evaluation of the ATTUNE Revision System in Complex Primary Total Knee Arthroplasty	2019
2019-10-07	Bayer Healthcare Pharmaceuticals Inc.	$130	Research payment	Cash or cash equivalent	Xarelto Drug, Cardio-pulmonary	BAY59-7939 2.5mg reduction atherothrombotic events vs. ASA	2019
2019-10-04	Genentech, Inc.	$11,460	Research payment	Cash or cash equivalent	Avastin Biological, BioOncology	A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM	2019
2019-10-04	W. L. Gore & Associates, Inc.	$4,810	Research payment	Cash or cash equivalent	Product in Development Device, Devices	GORE EXCLUDER Conformable Endoprosthesis	2019

The latest 200 records of 969.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Lebanon, NH, county Grafton County, NH, state New Hampshire; placed by its city name.

Measure	Place (city or town) Lebanon, NH	County Grafton County, NH	State New Hampshire
Population B01003	14,999	92,120	1,394,868
Population, 2020 census P1	14,282	91,118	1,377,529
Median age B01002	38.9	44.1	43.3
Under 18 B01001	14.6%	15.6%	18.2%
65 and over B01001	21.4%	23.0%	20.1%
Households B11001	6,917	37,107	555,822
Foreign born B05002	8.6%	5.6%	6.1%
Median household income B19013	$98,147	$88,261	$99,031
Median family income B19113	$120,046	$109,351	$122,715
Per capita income B19301	$56,599	$52,790	$52,798
Poverty rate B17001	7.0%	10.4%	7.2%
Unemployment rate B23025	0.8%	3.2%	3.3%
Civilian labor force B23025	9,352	48,140	775,826
Mean commute (minutes) B08013	14.0	22.2	26.7
Bachelor's degree or higher B15003	57.5%	46.7%	40.6%
Housing units B25001	7,855	51,920	648,472
Owner-occupied B25003	51.2%	71.3%	72.8%
Renters B25003	48.8%	28.7%	27.2%
Median home value B25077	$385,400	$344,500	$402,500
Median gross rent B25064	$1,744	$1,301	$1,491
White, not Hispanic B03002	84.3%	87.5%	86.9%
Black B03002	0.7%	1.1%	1.3%
Hispanic or Latino B03002	3.1%	2.9%	4.7%
Asian B03002	6.7%	3.5%	2.6%
American Indian and Alaska Native B03002	0.1%	0.1%	0.1%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Lebanon, NH.